Home > Cashflow Statement > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Net Cash Inflow / Outflow

    Back to Cashflow Statement
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Net Cash Inflow / Outflow ₹-251 Cr₹-119 Cr₹300 Cr₹6.03 Cr₹-102 Cr

What is the latest Net Cash Inflow / Outflow ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Net Cash Inflow / Outflow ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹-251 Cr based on Mar2023 Consolidated results.
Year Net Cash Inflow / Outflow
Mar2023₹-251 Cr
Mar2022₹-119 Cr
Mar2021₹300 Cr
Mar2020₹6.03 Cr
Mar2019₹-102 Cr

How is Net Cash Inflow / Outflow of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Net Cash Inflow / Outflow % Change
Mar2023 ₹-251 Cr
Negative
Mar2022 ₹-119 Cr
Negative
Mar2021 ₹300 Cr
4,877.27
Mar2020 ₹6.03 Cr
Positive
Mar2019 ₹-102 Cr -

Compare Net Cash Inflow / Outflow of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹36,128.8 Cr 9.5% 8.6% 64.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹360,920.0 Cr -2.3% -6.5% 55.3% Stock Analytics
CIPLA ₹113,794.0 Cr 4.1% -4.8% 55.6% Stock Analytics
DIVIS LABORATORIES ₹106,860.0 Cr 7.8% 17.4% 20.3% Stock Analytics
DR REDDYS LABORATORIES ₹104,316.0 Cr 4% 0.8% 29.4% Stock Analytics
ZYDUS LIFESCIENCES ₹95,380.9 Cr -1.2% -5.2% 83.9% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

9.5%

8.6%

64.8%

SENSEX

0.9%

1.5%

23.6%


You may also like the below Video Courses